{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:23:36Z","timestamp":1787142216416,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.leukres.2025.107662","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:17:53Z","timestamp":1738685873000},"page":"107662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML),"],"prefix":"10.1016","volume":"150","author":[{"given":"Zena","family":"Komrokji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla Al","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoer","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-1961","authenticated-orcid":false,"given":"Onyee","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongseok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lancet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kuykendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-5269","authenticated-orcid":false,"given":"Rami S.","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2025.107662_bib1","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41375-021-01207-3","article-title":"Chronic myelomonocytic leukemia diagnosis and management","volume":"35","author":"Chan","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.107662_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5045\/br.2021.2020321","article-title":"Diagnosis and treatment of chronic myelomonocytic leukemia","volume":"56","author":"Kwon","year":"2021","journal-title":"Blood Res"},{"key":"10.1016\/j.leukres.2025.107662_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ajh.26455","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2025.107662_bib4","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","article-title":"The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations","volume":"3","author":"Franzini","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2025.107662_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2643-3230.BCD-21-0217","article-title":"Progenitor hierarchy of Chronic Myelomonocytic Leukemia identifies inflammatory monocytic-biased trajectory linked to worse outcomes","volume":"3","author":"Ferrall-Fairbanks","year":"2022","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.leukres.2025.107662_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2009020213","article-title":"Reassessment of albumin as a nutritional marker in kidney disease","volume":"21","author":"Friedman","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.leukres.2025.107662_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.leukres.2025.107662_bib8","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107662_bib9","first-page":"4685","article-title":"Albumin is a prognostic factor for response and overall survival in relapsed or refractory acute myeloid leukemia (AML)","volume":"114","author":"Komrokji","year":"2009","journal-title":"ASH Annu. Meet. Abstr."},{"key":"10.1016\/j.leukres.2025.107662_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ajh.23303","article-title":"Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes","volume":"87","author":"Komrokji","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2025.107662_bib11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.107662_bib12","first-page":"97","article-title":"Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age?","volume":"12","author":"Yokus","year":"2022","journal-title":"Am. J. Blood Res"},{"key":"10.1016\/j.leukres.2025.107662_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clml.2019.01.002","article-title":"Predictive model for infection risk in myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia patients treated with azacitidine; azacitidine infection risk model: the polish adult leukemia group study","volume":"19","author":"M\u0105dry","year":"2019","journal-title":"Clin. Lymphoma, Myeloma Leuk."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:14:49Z","timestamp":1740744889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":13,"alternative-id":["S0145212625000220"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107662","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML),","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107662"}}